(4S,5S)-4-メチル-5-フェニルオキサゾリジン-2-オン

危険有害性情報のコード(GHS)

• 絵表示(GHS)

  

• 注意喚起語

  Warning

• 危険有害性情報

  H302：飲み込むと有害

  H315：皮膚刺激

  H319：強い眼刺激

  H335：呼吸器への刺激のおそれ

• 注意書き

  P261：粉じん/煙/ガス/ミスト/蒸気/スプレーの吸入を避ける こと。

  P305+P351+P338：眼に入った場合：水で数分間注意深く洗うこと。次にコ ンタクトレンズを着用していて容易に外せる場合は外す こと。その後も洗浄を続けること。

(4S,5S)-4-メチル-5-フェニルオキサゾリジン-2-オン 価格

(4S,5S)-4-メチル-5-フェニルオキサゾリジン-2-オン 化学特性,用途語,生産方法

• 外観

  白色～淡黄色、結晶性粉末～粉末。

• 化学的特性

  white to light yellow crystal powde

• 使用

  (4R,5S)-4-Methyl-5-phenyloxazolidinone is used as effective chiral auxiliary for conjugate addition asymmetric synthesis of (-)-aplysillamide B.

• 製造方法

  To a solution of (1S,2R)-norephedrine (40 g, 0.26 mol) in toluene (400 mL) was added diethyl carbonate (37 mL, 0.32 mol). The mixture was heated to reflux (under Ar) while 40 mL of solvent was removed through the use of a Dean–Stark apparatus. The mixture was allowed to cool for 20 min, and then sodium methoxide (1 g) was added. Upon reheating, an EtOH/toluene azeotropic mixture was removed at 75–77 °C. After 3 h, the reaction was complete and the temperature of the mixture had increased to 125 °C. The mixture was left to stand at room temperature for 16 h, whereupon (4R,5S)-4-methyl-5-phenyloxazolidin-2-one (40.6 g) crystallized and could be collected. The solvent was removed from the filtrate in vacuo and the residue was redissolved in EtOAc (250 mL). This solution was washed with brine (50 mL) and a precipitate was removed by filtration. The solvent was then removed in vacuo and toluene (50 mL) was added to the residue. Removal of the toluene by distillation yielded oily crystals of the oxazolidinone, which were washed with Et2O to afford 4.5 g (total 45 g, 97%).

(4S,5S)-4-メチル-5-フェニルオキサゾリジン-2-オン 上流と下流の製品情報

(4S,5S)-4-メチル-5-フェニルオキサゾリジン-2-オン 生産企業

Global(135)Suppliers

(4S,5S)-4-メチル-5-フェニルオキサゾリジン-2-オン スペクトルデータ(¹HNMR、FT-IR、IR、Raman)

77943-39-6, (4S,5S)-4-メチル-5-フェニルオキサゾリジン-2-オン キーワード